Table 1.

Rates of SVR in Patients Receiving Ledipasvir/Sofosbuvir or Ledipasvir/Sofosbuvir/Ribavirin for 8 Weeks, by Population Subgroup and HCV RNA Level, ION-3

	HCV RNA Level
	<6 million IU/mL			≥6 million IU/mL
	SVR	Total	SVR Rate	SVR	Total	SVR Rate
rs12979860
CC	66	66	100%	45	47	96%
CT/TT	186	191	97%	106	119	89%
Sex
Female	126	126	100%	52	54	96%
Male	126	131	96%	99	112	88%

Abbreviations: HCV, hepatitis C virus; SVR, sustained virological response.